Gene therapy for spinal cord disorders

Details for Australian Patent Application No. 2006242129 (hide)

Owner Genzyme Corporation

Inventors Passini, Marco; Cheng, Seng; Dodge, James; Shihabuddin, Lamya

Agent Davies Collison Cave

Pub. Number AU-A-2006242129

PCT Pub. Number WO2006/119341

Priority 60/677,213 02.05.05 US; 60/790,217 08.04.06 US

Filing date 2 May 2006

Wipo publication date 9 November 2006

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

Event Publications

22 November 2007 PCT application entered the National Phase

  PCT publication WO2006/119341 Priority application(s): WO2006/119341

21 February 2008 Amendment Made

  The nature of the amendment is: Add co-inventor name to read O'Riordan, Catherine R.

1 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006242132-Method and system for wearable vital signs and physiology, activity, and environmental monitoring

2006242125-Resource allocation in multi-access point wireless networks